MedPath

Prospective trial of Radiofrequency Catheter Ablation of High Dominant Frequencies after Pulmonary Vein Isolation in Non-paroxysmal Atrial Fibrillatio

Not Applicable
Recruiting
Conditions
on-paroxysmal Atrial Fibrillation
Registration Number
JPRN-UMIN000042543
Lead Sponsor
Tohoku Medical and Pharmaceutical University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
440
Inclusion Criteria

Not provided

Exclusion Criteria

(1)other investigational study involvement (2)Mitral stenosis (3)artificial valve (4)Patients with cardiovascular events (stroke, myocardial infarction, heart failure requiring hospitalization) or bleeding requiring hospitalization within one month before registration (5)life expectancy within one year (6)LA thrombus (7)left atrial size>50 mm (8)prior AF ablation (9)Patients who cannot continue taking anticoagulants (10)pregnancy (11)thyroid disease (12)tumors (13)LVEF<50% (14)continuous AF duration more than 7 years (15)HCM,DCM (16)renal function<eGFR50ml/m/1.73m2dl

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The atrial fibrillation freedom off antiarrhythmic drugs after ablation at high-DF sites after PVI of non-paroxysmal AF during 12 months of follow-up
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath